| 1 |
35433455 | Metagenomic Analyses Reveal Distinct Gut Microbiota Signature for Predicting the Neoadjuvant Chemotherapy Responsiveness in Breast Cancer Patients. | 2022 |
1 |
| 2 |
35526096 | LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation. | 2022 May 6 |
1 |
| 3 |
32878426 | Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3- CD4+ T Cells in Biliary Tract Cancer. | 2021 Jan |
1 |
| 4 |
34144673 | Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood. | 2021 Jun 18 |
1 |
| 5 |
32957741 | Anti-Telomerase CD4+ Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 Trials. | 2020 Sep 17 |
1 |
| 6 |
30952714 | Cisplatin Augments Antitumor T-Cell Responses Leading to a Potent Therapeutic Effect in Combination With PD-L1 Blockade. | 2019 Apr |
1 |
| 7 |
28251947 | [Cisplatin-induced apoptotic endonuclease EndoG inhibits telomerase activity and causes malignant transformation of human CD4+ T lymphocytes]. | 2017 Jan |
2 |
| 8 |
25659373 | Suppressive effects of gemcitabine plus cisplatin chemotherapy on regulatory T cells in nonsmall-cell lung cancer. | 2015 Apr |
2 |
| 9 |
25531529 | Cancer immunotherapy employing an innovative strategy to enhance CD4+ T cell help in the tumor microenvironment. | 2014 |
1 |
| 10 |
23600838 | The effects of chemotherapeutic drugs on human monocyte-derived dendritic cell differentiation and antigen presentation. | 2013 Jun |
1 |
| 11 |
21822560 | The immunological impact of neoadjuvant chemotherapy on the tumor microenvironment of esophageal squamous cell carcinoma. | 2012 May |
1 |
| 12 |
21949094 | IL-33 exacerbates acute kidney injury. | 2011 Nov |
2 |
| 13 |
19020751 | Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer. | 2008 Dec |
1 |